Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Johnny Daniels
Observed names:
Daniels, J.,
Daniels, Johnny,
J. Daniels,
Johnny F. Daniels,
Johnny Flippie Daniels
Institution:
Médecins Sans Frontières
Observed institutions:
Médecins Sans Frontières,
Médecins Sans Frontières,
Médecins Sans Frontières,
Médecins Sans Frontières,
Médecins Sans Frontières,
Médecins Sans Frontières
show all 6
ORCID:
0009-0009-1203-0446
Observed ORCID:
0009-0009-1203-0446
OpenAlex ID:
A5112410721
Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa
2014
·
H. Cox
, J. Hughes
, et al.
·
The International Journal of Tuberculosis and Lung Disease
·
110
Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South Africa
2015
·
Helen S. Cox
, Johnny F. Daniels
, et al.
·
Open Forum Infectious Diseases
·
84
PDF
Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa
2018
·
Erika Mohr
, Jennifer Hughes
, et al.
·
European Respiratory Journal
·
49
PDF
Effect of compensatory evolution in the emergence and transmission of rifampicin-resistant Mycobacterium tuberculosis in Cape Town, South Africa: a genomic epidemiology study
2023
·
Galo A Goig
, Fabrizio Menardo
, et al.
·
The Lancet Microbe
·
48
PDF
Loss from Treatment for Drug Resistant Tuberculosis: Risk Factors and Patient Outcomes in a Community-Based Program in Khayelitsha, South Africa
2015
·
Sizulu Moyo
, Helen S. Cox
, et al.
·
PLoS ONE
·
47
PDF
Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study
2021
·
Helen Cox
, Zubeida Salaam-Dreyer
, et al.
·
The Lancet Microbe
·
30
PDF
Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort Study
2022
·
Helen Cox
, Galo A. Goig
, et al.
·
Journal of Clinical Microbiology
·
29
Outcomes in Adolescents Undergoing Treatment for Drug-resistant Tuberculosis in Cape Town, South Africa, 2008-2013
2014
·
Sizulu Moyo
, Jennifer J Furin
, et al.
·
Archives of Pediatric Infectious Diseases
·
28
PDF
Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa
2021
·
Zubeida Salaam-Dreyer
, Elizabeth M. Streicher
, et al.
·
Antimicrobial Agents and Chemotherapy
·
26
Programmatic treatment outcomes in HIV-infected and uninfected drug-resistant TB patients in Khayelitsha, South Africa
2015
·
E. Mohr
, V. Cox
, et al.
·
Transactions of the Royal Society of Tropical Medicine and Hygiene
·
25
Outcomes of Children Born to Pregnant Women With Drug-resistant Tuberculosis Treated With Novel Drugs in Khayelitsha, South Africa: A Report of Five Patients
2021
·
Rebecca Acquah
, Erika Mohr-Holland
, et al.
·
The Pediatric Infectious Disease Journal
·
19
“This is not my body”: Therapeutic experiences and post-treatment health of people with rifampicin-resistant tuberculosis
2021
·
Marian Loveday
, Sindisiwe Hlangu
, et al.
·
PLoS ONE
·
16
PDF
Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success
2015
·
Johnny Flippie Daniels
, Mohammed Khogali
, et al.
·
PLoS ONE
·
16
PDF
DOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting
2017
·
Erika Mohr
, Johnny Daniels
, et al.
·
PLoS ONE
·
15
PDF
Tuberculosis Diagnosis and Preventive Monotherapy Among Children and Adolescents Exposed to Rifampicin-Resistant Tuberculosis in the Household
2023
·
Ivy Apolisi
, Helen Cox
, et al.
·
Open Forum Infectious Diseases
·
13
PDF
Early mortality during rifampicin-resistant TB treatment
2022
·
E. Mohr-Holland
, J. Daniels
, et al.
·
The International Journal of Tuberculosis and Lung Disease
·
13
Implementing a Substance-Use Screening and Intervention Program for People Living with Rifampicin-Resistant Tuberculosis: Pragmatic Experience from Khayelitsha, South Africa
2022
·
Anja Reuter
, Buci Beko
, et al.
·
Tropical Medicine and Infectious Disease
·
12
PDF
Missed opportunities for earlier diagnosis of rifampicin-resistant tuberculosis despite access to Xpert® MTB/RIF
2017
·
E. Mohr
, J. Daniels
, et al.
·
The International Journal of Tuberculosis and Lung Disease
·
9
Causes of loss to follow-up from drug-resistant TB treatment in Khayelitsha, South Africa
2022
·
B. Memani
, B. Beko
, et al.
·
Public Health Action
·
7
Pediatric delamanid treatment for children with rifampicin-resistant TB
2022
·
N. Tyeku
, I. Apolisi
, et al.
·
The International Journal of Tuberculosis and Lung Disease
·
6
A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients
2021
·
E. Mohr-Holland
, J. Daniels
, et al.
·
The International Journal of Tuberculosis and Lung Disease
·
5
Emergence of Bedaquiline Resistance After Completion of Bedaquiline-based Drugresistant Tb Treatment: a Case Study From South Africa
2018
·
M. De Vos
, S. Ley
, et al.
·
Russian Journal of Infection and Immunity
·
4
PDF
Correspondence regarding “Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa”
2020
·
Erika Mohr-Holland
, Anja Reuter
, et al.
·
European Respiratory Journal
·
2
PDF
Waiting is no longer an option for household contacts of people with drug-resistant tuberculosis
2024
·
Jean Pannikottu
, Anja Reuter
, et al.
·
The Lancet Infectious Diseases
·
1
Household contact management for rifampicin-resistant tuberculosis
2022
·
Anja Reuter
, Ivy Apolisi
, et al.
·
The Lancet Global Health
·
1
Show more works
View as search
Works count:
34
Citation count:
617
H-index:
14
I10-index:
17
Year
Topic
Type